"Medicare Part D" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A stand-alone drug plan offered by insurers and other private companies to beneficiaries that receive their Medicare Part A and/or B benefits through the Original Medicare Plan. It includes Medicare Private Fee-for-Service Plans that do not offer prescription drug coverage and Medicare Cost Plans offering Medicare prescription drug coverage. The plan was enacted as the Medicare Prescription Drug, Improvement and Modernization Act of 2003 with coverage beginning January 1, 2006.
| Descriptor ID |
D054524
|
| MeSH Number(s) |
N03.219.521.576.343.575.500 N03.219.521.576.343.840.938 N03.706.615.752
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Medicare Part D".
Below are MeSH descriptors whose meaning is more specific than "Medicare Part D".
This graph shows the total number of publications written about "Medicare Part D" by people in this website by year, and whether "Medicare Part D" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 2 | 0 | 2 |
| 2011 | 1 | 0 | 1 |
| 2012 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 3 | 0 | 3 |
| 2015 | 1 | 0 | 1 |
| 2017 | 1 | 1 | 2 |
| 2018 | 0 | 1 | 1 |
| 2019 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
| 2021 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Medicare Part D" by people in Profiles.
-
Stroupe KT, Nazi K, Hogan TP, Poggensee L, Wakefield B, Martinez RN, Etingen B, Shimada S, Suda KJ, Huo Z, Cao L, Smith BM. Web-based patient portal use and medication overlap from VA and private-sector pharmacies among older veterans. J Manag Care Spec Pharm. 2021 Aug; 27(8):983-994.
-
Nekui F, Galbraith AA, Briesacher BA, Zhang F, Soumerai SB, Ross-Degnan D, Gurwitz JH, Madden JM. Cost-related Medication Nonadherence and Its Risk Factors Among Medicare Beneficiaries. Med Care. 2021 01; 59(1):13-21.
-
Zhao D, Shridharmurthy D, Alcusky MJ, Yuan Y, Nunes AP, Hume AL, Baek J, Lapane KL. The Prevalence and Factors Associated with Antiepileptic Drug Use in US Nursing Home Residents. Drugs Aging. 2020 02; 37(2):137-145.
-
Liu SH, Hunnicutt JN, Ulbricht CM, Dub? CE, Hume AL, Lapane KL. Adjuvant Use and the Intensification of Pharmacologic Management for Pain in Nursing Home Residents with Cancer: Data from a US National Database. Drugs Aging. 2019 06; 36(6):549-557.
-
Hunnicutt JN, Hume AL, Ulbricht CM, Tjia J, Lapane KL. Long-acting opioid initiation in US nursing homes. Pharmacoepidemiol Drug Saf. 2019 01; 28(1):31-38.
-
Massey C, Aungst TD, Evans P, Bartlett D, Silva MA. Cost savings impact of a pharmacist-initiated teleservice program for Medicare Part D reviews. J Am Pharm Assoc (2003). 2018 Jan - Feb; 58(1):56-60.
-
Hunnicutt JN, Chrysanthopoulou SA, Ulbricht CM, Hume AL, Tjia J, Lapane KL. Prevalence of Long-Term Opioid Use in Long-Stay Nursing Home Residents. J Am Geriatr Soc. 2018 01; 66(1):48-55.
-
Sacks NC, Burgess JF, Cabral HJ, Pizer SD. Myopic and Forward Looking Behavior in Branded Oral Anti-Diabetic Medication Consumption: An Example from Medicare Part D. Health Econ. 2017 06; 26(6):753-764.
-
Sacks NC, Burgess JF, Cabral HJ, McDonnell ME, Pizer SD. The Effects of Cost Sharing on Adherence to Medications Prescribed for Concurrent Use: Do Definitions Matter? J Manag Care Spec Pharm. 2015 Aug; 21(8):678-87.
-
Briesacher BA, Madden JM, Zhang F, Fouayzi H, Ross-Degnan D, Gurwitz JH, Soumerai SB. Did Medicare Part D Affect National Trends in Health Outcomes or Hospitalizations? A Time-Series Analysis. Ann Intern Med. 2015 Jun 16; 162(12):825-33.